Fig. 6From: Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatmentThe comparison between pretreatment and co-treatment of MitoQ (A) and SKQ1 (B) on Dox-induced cell damage. Pretreatment and co-treatment of MitoQ and SKQ1 significantly protected cells against Dox by demonstrating higher cell viability. Moreover, pretreatment of MitoQ, not SKQ1, exerted significantly higher protection than co-treatment at higher doses. *p < 0.05; **p < 0.01 vs Dox; ##p < 0.01 vs MitoQ co-treatmentBack to article page